James E. Miskin

Windrush Court, Transport Way
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Risks of replication-competent retro/lentivirus from associated vector systems: Is it time for a roadmap toward reduced testing?

Risks of replication-competent retro/lentivirus from associated vector systems: Is it time for a roadmap toward reduced testing?

Journal: Molecular therapy. Methods & clinical development

Published: October 27, 2025

Auto-transduction in lentiviral vector bioprocessing: A quantitative assessment and a novel inhibition strategy.

Auto-transduction in lentiviral vector bioprocessing: A quantitative assessment and a novel inhibition strategy.

Journal: Biotechnology and bioengineering

Published: June 28, 2024

What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence.

What is the real value of omics data? Enhancing research outcomes and securing long-term data excellence.

Journal: Nucleic acids research

Published: June 07, 2024

Degradation of specific glycosaminoglycans improves transfection efficiency and vector production in transient lentiviral vector manufacturing processes.

Degradation of specific glycosaminoglycans improves transfection efficiency and vector production in transient lentiviral vector manufacturing processes.

Journal: Frontiers in bioengineering and biotechnology

Published: March 29, 2024

Lentiviral vector determinants of anion-exchange chromatography elution heterogeneity.

Lentiviral vector determinants of anion-exchange chromatography elution heterogeneity.

Journal: Biotechnology and bioengineering

Published: February 28, 2024

Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture.

Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture.

Journal: Molecular therapy. Methods & clinical development

Published: December 02, 2023

Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing.

Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing.

Journal: Scientific reports

Published: August 26, 2022

Global Manufacturing of CAR T Cell Therapy.

Global Manufacturing of CAR T Cell Therapy.

Journal: Molecular therapy. Methods & clinical development

Published: September 28, 2016

Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.

Development of a replication-competent lentivirus assay for dendritic cell-targeting lentiviral vectors.

Journal: Molecular therapy. Methods & clinical development

Published: January 28, 2015

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.

Journal: Lancet (London, England)

Published: January 14, 2014

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

Journal: PloS one

Published: October 25, 2013

Not reinventing the wheel: applying the 3Rs concepts to viral vector gene therapy biodistribution studies.

Not reinventing the wheel: applying the 3Rs concepts to viral vector gene therapy biodistribution studies.

Journal: Human gene therapy. Clinical development

Published: May 23, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026